Global Angiogenesis Assay 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR012509957

Publication Date:

January 27, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Angiogenesis Assay market size was valued at US$ 20.1 million in 2024 and is forecast to a readjusted size of USD 33.4 million by 2031 with a CAGR of 7.6% during review period.
Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.
This report is a detailed and comprehensive analysis for global Angiogenesis Assay market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Angiogenesis Assay market size and forecasts, in consumption value ($ Million), 2020-2031
Global Angiogenesis Assay market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Angiogenesis Assay market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Angiogenesis Assay market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Angiogenesis Assay
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Angiogenesis Assay market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, Bio-Techne, Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Angiogenesis Assay market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
In Vitro Assay Kit
In Vivo Assay Kit
麻豆原创 segment by Application
Academic Institution
Biotech Companies
麻豆原创 segment by players, this report covers
Abcam
Bio-Techne
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Angiogenesis Assay product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Angiogenesis Assay, with revenue, gross margin, and global market share of Angiogenesis Assay from 2020 to 2025.
Chapter 3, the Angiogenesis Assay competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Angiogenesis Assay market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Angiogenesis Assay.
Chapter 13, to describe Angiogenesis Assay research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Angiogenesis Assay by Type
1.3.1 Overview: Global Angiogenesis Assay 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Angiogenesis Assay Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 In Vitro Assay Kit
1.3.4 In Vivo Assay Kit
1.4 Global Angiogenesis Assay 麻豆原创 by Application
1.4.1 Overview: Global Angiogenesis Assay 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Academic Institution
1.4.3 Biotech Companies
1.5 Global Angiogenesis Assay 麻豆原创 Size & Forecast
1.6 Global Angiogenesis Assay 麻豆原创 Size and Forecast by Region
1.6.1 Global Angiogenesis Assay 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Angiogenesis Assay 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Angiogenesis Assay 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Angiogenesis Assay 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Angiogenesis Assay 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Angiogenesis Assay 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Angiogenesis Assay 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Abcam
2.1.1 Abcam Details
2.1.2 Abcam Major Business
2.1.3 Abcam Angiogenesis Assay Product and Solutions
2.1.4 Abcam Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Abcam Recent Developments and Future Plans
2.2 Bio-Techne
2.2.1 Bio-Techne Details
2.2.2 Bio-Techne Major Business
2.2.3 Bio-Techne Angiogenesis Assay Product and Solutions
2.2.4 Bio-Techne Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Bio-Techne Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Angiogenesis Assay Product and Solutions
2.3.4 Thermo Fisher Scientific Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Cell Biolabs, Inc.
2.4.1 Cell Biolabs, Inc. Details
2.4.2 Cell Biolabs, Inc. Major Business
2.4.3 Cell Biolabs, Inc. Angiogenesis Assay Product and Solutions
2.4.4 Cell Biolabs, Inc. Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Cell Biolabs, Inc. Recent Developments and Future Plans
2.5 BioVision, Inc
2.5.1 BioVision, Inc Details
2.5.2 BioVision, Inc Major Business
2.5.3 BioVision, Inc Angiogenesis Assay Product and Solutions
2.5.4 BioVision, Inc Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 BioVision, Inc Recent Developments and Future Plans
2.6 PromoCell GmbH
2.6.1 PromoCell GmbH Details
2.6.2 PromoCell GmbH Major Business
2.6.3 PromoCell GmbH Angiogenesis Assay Product and Solutions
2.6.4 PromoCell GmbH Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 PromoCell GmbH Recent Developments and Future Plans
2.7 Merck KGaA
2.7.1 Merck KGaA Details
2.7.2 Merck KGaA Major Business
2.7.3 Merck KGaA Angiogenesis Assay Product and Solutions
2.7.4 Merck KGaA Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Merck KGaA Recent Developments and Future Plans
2.8 Kollodis BioSciences
2.8.1 Kollodis BioSciences Details
2.8.2 Kollodis BioSciences Major Business
2.8.3 Kollodis BioSciences Angiogenesis Assay Product and Solutions
2.8.4 Kollodis BioSciences Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Kollodis BioSciences Recent Developments and Future Plans
2.9 Sartorius (Essen BioScience)
2.9.1 Sartorius (Essen BioScience) Details
2.9.2 Sartorius (Essen BioScience) Major Business
2.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Product and Solutions
2.9.4 Sartorius (Essen BioScience) Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Sartorius (Essen BioScience) Recent Developments and Future Plans
2.10 Creative Bioarray
2.10.1 Creative Bioarray Details
2.10.2 Creative Bioarray Major Business
2.10.3 Creative Bioarray Angiogenesis Assay Product and Solutions
2.10.4 Creative Bioarray Angiogenesis Assay Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Creative Bioarray Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Angiogenesis Assay Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Angiogenesis Assay by Company Revenue
3.2.2 Top 3 Angiogenesis Assay Players 麻豆原创 Share in 2024
3.2.3 Top 6 Angiogenesis Assay Players 麻豆原创 Share in 2024
3.3 Angiogenesis Assay 麻豆原创: Overall Company Footprint Analysis
3.3.1 Angiogenesis Assay 麻豆原创: Region Footprint
3.3.2 Angiogenesis Assay 麻豆原创: Company Product Type Footprint
3.3.3 Angiogenesis Assay 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Angiogenesis Assay Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Angiogenesis Assay 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Angiogenesis Assay Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Angiogenesis Assay 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Angiogenesis Assay Consumption Value by Type (2020-2031)
6.2 North America Angiogenesis Assay 麻豆原创 Size by Application (2020-2031)
6.3 North America Angiogenesis Assay 麻豆原创 Size by Country
6.3.1 North America Angiogenesis Assay Consumption Value by Country (2020-2031)
6.3.2 United States Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Angiogenesis Assay Consumption Value by Type (2020-2031)
7.2 Europe Angiogenesis Assay Consumption Value by Application (2020-2031)
7.3 Europe Angiogenesis Assay 麻豆原创 Size by Country
7.3.1 Europe Angiogenesis Assay Consumption Value by Country (2020-2031)
7.3.2 Germany Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Angiogenesis Assay Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Angiogenesis Assay Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Angiogenesis Assay 麻豆原创 Size by Region
8.3.1 Asia-Pacific Angiogenesis Assay Consumption Value by Region (2020-2031)
8.3.2 China Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Angiogenesis Assay Consumption Value by Type (2020-2031)
9.2 South America Angiogenesis Assay Consumption Value by Application (2020-2031)
9.3 South America Angiogenesis Assay 麻豆原创 Size by Country
9.3.1 South America Angiogenesis Assay Consumption Value by Country (2020-2031)
9.3.2 Brazil Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Angiogenesis Assay Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Angiogenesis Assay Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Angiogenesis Assay 麻豆原创 Size by Country
10.3.1 Middle East & Africa Angiogenesis Assay Consumption Value by Country (2020-2031)
10.3.2 Turkey Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Angiogenesis Assay 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Angiogenesis Assay 麻豆原创 Drivers
11.2 Angiogenesis Assay 麻豆原创 Restraints
11.3 Angiogenesis Assay Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Angiogenesis Assay Industry Chain
12.2 Angiogenesis Assay Upstream Analysis
12.3 Angiogenesis Assay Midstream Analysis
12.4 Angiogenesis Assay Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Abcam
Bio-Techne
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.